139 related articles for article (PubMed ID: 8241956)
1. The tetrapeptide AcSerAspLysPro (Seraspenide), a hematopoietic inhibitor, may reduce the in vitro toxicity of 3'-azido-3'-deoxythymidine to human hematopoietic progenitors.
Grillon C; Bonnet D; Mary JY; Lenfant M; Najman A; Guigon M
Stem Cells; 1993 Sep; 11(5):455-64. PubMed ID: 8241956
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human bone marrow progenitors by the synthetic tetrapeptide AcSDKP.
Guigon M; Bonnet D; Lemoine F; Kobari L; Parmentier C; Mary JY; Najman A
Exp Hematol; 1990 Nov; 18(10):1112-5. PubMed ID: 2209766
[TBL] [Abstract][Full Text] [Related]
3. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
[TBL] [Abstract][Full Text] [Related]
4. Influence of interleukin-3 on zidovudine (AZT)-induced in vitro toxicity to human hematopoietic progenitors.
Gallicchio VS; Hughes NK
Int J Cell Cloning; 1992 Mar; 10(2):99-104. PubMed ID: 1545155
[TBL] [Abstract][Full Text] [Related]
5. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Scheding S; Media JE; Nakeff A
Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
[TBL] [Abstract][Full Text] [Related]
6. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
Gallicchio VS; Hughes NK; Tse KF
Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
[TBL] [Abstract][Full Text] [Related]
7. The tetrapeptide AcSDKP, an inhibitor of the cell-cycle status for normal human hematopoietic progenitors, has no effect on leukemic cells.
Bonnet D; Césaire R; Lemoine F; Aoudjhane M; Najman A; Guigon M
Exp Hematol; 1992 Feb; 20(2):251-5. PubMed ID: 1544396
[TBL] [Abstract][Full Text] [Related]
8. The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells.
Bhalla K; Birkhofer M; Grant S; Graham G
Exp Hematol; 1989 Jan; 17(1):17-20. PubMed ID: 2783247
[TBL] [Abstract][Full Text] [Related]
9. Photoprotection of normal human hematopoietic progenitors by the tetrapeptide N-AcSDKP.
Coutton C; Guigon M; Bohbot A; Ferrani K; Oberling F
Exp Hematol; 1994 Oct; 22(11):1076-80. PubMed ID: 7925774
[TBL] [Abstract][Full Text] [Related]
10. [Demonstration of a protector effect of interleukin-1 against hematologic toxicity of azidothymidine (AZT)].
Arock M; Dedenon A; Damais C; Averlant G; Guillosson JJ
C R Seances Soc Biol Fil; 1992; 186(3):206-14. PubMed ID: 1493577
[TBL] [Abstract][Full Text] [Related]
11. Activity of acetyl-n-ser-asp-lys-pro (AcSDKP) on hematopoietic progenitor cells in short-term and long-term murine bone marrow cultures.
Jackson JD; Yan Y; Ewel C; Talmadge JE
Exp Hematol; 1996 Feb; 24(3):475-81. PubMed ID: 8599978
[TBL] [Abstract][Full Text] [Related]
12. Prevention of the hematopoietic toxicity associated with zidovudine in vivo with IL-1 alone or in combination with GM-CSF administered to normal mice.
Gallicchio VS; Hughes NK; Tse KF; Gaines H
Growth Factors; 1993; 9(3):177-83. PubMed ID: 8274295
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS.
Ganser A; Greher J; Völkers B; Staszewski S; Hoelzer D
Exp Hematol; 1989 May; 17(4):321-5. PubMed ID: 2540017
[TBL] [Abstract][Full Text] [Related]
14. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
15. Reversible inhibitory effects and absence of toxicity of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in human long-term bone marrow culture.
Bonnet D; Lemoine FM; Khoury E; Pradelles P; Najman A; Guigon M
Exp Hematol; 1992 Nov; 20(10):1165-9. PubMed ID: 1385195
[TBL] [Abstract][Full Text] [Related]
16. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
Wierenga PK; Konings AW
Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hematopoietic progenitor cell proliferation by ethanol in human immunodeficiency virus type 1 tat-expressing transgenic mice.
Prakash O; Rodriguez VE; Tang ZY; Zhou P; Coleman R; Dhillon G; Shellito JE; Nelson S
Alcohol Clin Exp Res; 2001 Mar; 25(3):450-6. PubMed ID: 11290858
[TBL] [Abstract][Full Text] [Related]
18. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
19. In vitro toxicity of A 3'-azido-3'-deoxythymidine and hydroxyurea combination on normal myeloid progenitors.
Lerza R; Castello G; Ballarino P; Mela GS; Tredici S; Arboscello E; Mencoboni M; Pannacciulli I
Anticancer Res; 1998; 18(4A):2755-8. PubMed ID: 9703941
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
Cardier JE; Erickson-Miller CL; Murphy MJ
Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]